KATHRYN CECIL: Open Payments
NPI 1053743658 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,460 in 68 payments from 18 companies in 2025. Trend: 2023 $1,087 · 2024 $1,439 · 2025 $1,460
Food & beverage: $1,460
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $333 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $268 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $145 |
| Ardelyx, Inc. | 6 | $135 |
| Janssen Biotech, Inc. | 6 | $130 |
| QOL Medical, LLC | 3 | $72 |
| Lilly USA, LLC | 3 | $66 |
| Phathom Pharmaceuticals, Inc. | 4 | $59 |
| Regeneron Healthcare Solutions, Inc. | 3 | $56 |
| Intercept Pharmaceuticals, Inc. | 2 | $42 |
Products named: XIFAXAN, IBSRELA, TREMFYA, ENTYVIO, RINVOQ, LINZESS, CREON, DUPIXENT.
Industry payments across KY — which companies pay providers there.
